New York restaurants offer smaller Ozempic-friendly meals

New York restaurants are introducing smaller "Ozempic menus" with significantly reduced portion sizes. This trend caters to patrons using appetite-suppressing GLP-1 medications. The shift reflects a growing demand for smaller meals, with establishments offering "Teeny Weeny Mini Meals" and single-item dishes. Restaurateurs see this as a business opportunity and a way to reduce food waste. GLP-1 medications, like Ozempic, are increasingly used for weight loss, impacting dining habits. While offering benefits, these drugs also carry potential side effects and risks of weight regain.